Doheny Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Sell
4,264
-270
-6% -$274K 2.56% 11
2025
Q4
$4.87M Sell
4,534
-7
-0.2% -$6.69K 2.98% 10
2025
Q3
$3.46M Buy
4,541
+560
+14% +$417K 2.2% 12
2025
Q2
$3.1M Buy
3,981
+35
+0.9% +$27.2K 2.17% 14
2025
Q1
$3.26M Buy
3,946
+513
+15% +$427K 2.55% 11
2024
Q4
$2.65M Sell
3,433
-537
-14% -$445K 1.98% 17
2024
Q3
$3.52M Buy
3,970
+90
+2% +$80.9K 2.4% 12
2024
Q2
$3.51M Buy
3,880
+24
+0.6% +$19.2K 2.5% 13
2024
Q1
$3M Buy
3,856
+3,209
+496% +$2.28M 2.47% 13
2023
Q4
$377K Sell
647
-353
-35% -$206K 0.37% 53
2023
Q3
$537K Hold
1,000
0.52% 49
2023
Q2
$469K Hold
1,000
0.4% 52
2023
Q1
$343K Hold
1,000
0.31% 58
2022
Q4
$366K Hold
1,000
0.42% 54
2022
Q3
$323K Buy
+1,000
New +$317K 0.32% 57
2022
Q1
$286K Hold
1,000
0.21% 68
2021
Q4
$276K Sell
1,000
-325
-25% -$82.4K 0.19% 73
2021
Q3
$306K Hold
1,325
0.22% 76
2021
Q2
$304K Sell
1,325
-1,500
-53% -$301K 0.2% 83
2021
Q1
$528K Hold
2,825
0.36% 68
2020
Q4
$477K Sell
2,825
-25
-0.9% -$3.73K 0.33% 66
2020
Q3
$422K Hold
2,850
0.35% 64
2020
Q2
$468K Hold
2,850
0.44% 56
2020
Q1
$375K Hold
2,850
0.3% 74
2019
Q4
$375K Hold
2,850
0.3% 74
2019
Q3
$319K Hold
2,850
0.28% 77
2019
Q2
$316K Hold
2,850
0.26% 79
2019
Q1
$370K Hold
2,850
0.31% 73
2018
Q4
$330K Hold
2,850
0.24% 72
2018
Q3
$306K Hold
2,850
0.16% 90
2018
Q2
$243K Hold
2,850
0.13% 91
2018
Q1
$221K Hold
2,850
0.12% 99
2017
Q4
$241K Hold
2,850
0.11% 99
2017
Q3
$244K Hold
2,850
0.11% 101
2017
Q2
$235K Hold
2,850
0.11% 96
2017
Q1
$240K Sell
2,850
-579
-17% -$46.4K 0.11% 102
2016
Q4
$252K Buy
3,429
+579
+20% +$43.1K 0.12% 98
2016
Q3
$229K Hold
2,850
0.12% 97
2016
Q2
$224K Hold
2,850
0.11% 98
2016
Q1
$205K Hold
2,850
0.11% 98
2015
Q4
$240K Hold
2,850
0.12% 99
2015
Q3
$239K Hold
2,850
0.12% 96
2015
Q2
$238K Hold
2,850
0.11% 106
2015
Q1
$207K Buy
+2,850
New +$203K 0.1% 109

Other funds holding LLY

Doheny Asset Management's LLY Position: Q1 2026 in Review

Doheny Asset Management reduced its Eli Lilly (LLY) stake by 6% in Q1 2026, selling an estimated $274K and leaving 4,264 shares worth $3.92M. The position accounts for 2.56% of the portfolio, ranked #11.

Doheny Asset Management first reported a position in LLY in Q1 2015 and has held it in 44 quarters since. The position peaked at $4.87M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Doheny Asset Management held 4,264 shares of Eli Lilly worth $3.92M as of Q1 2026.
  • Doheny Asset Management sold 270 Eli Lilly shares in Q1 2026, an estimated $274K.
  • Eli Lilly made up 2.56% of Doheny Asset Management's portfolio in Q1 2026, its #11 holding.
  • Doheny Asset Management first reported a position in Eli Lilly in Q1 2015 and has held it in 44 quarters since.
  • Doheny Asset Management's Eli Lilly position peaked at $4.87M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Doheny Asset Management's 13F filing for Q1 2026, filed 7 May 2026.